Cited by 181HIV Research and TreatmentImmunotherapy and Immune Responsesinterferon and immune responses

Interferon-Inducible Mechanism of Dendritic Cell-Mediated HIV-1 Dissemination Is Dependent on Siglec-1/CD169

Open access
Puryear, Wendy Blay, Akiyama, Hisashi, Geer, Suzanne D., Ramirez, Nora P., Yu, Xinwei, Reinhard, Björn M., Gummuluru, Suryaram·2013·PLoS Pathogens

Abstract

Human immunodeficiency virus type 1 (HIV-1) interactions with myeloid dendritic cells (DCs) can result in virus dissemination to CD4⁺ T cells via a trans infection pathway dependent on virion incorporation of the host cell derived glycosphingolipid (GSL), GM3. The mechanism of DC-mediated trans infection is extremely efficacious and can result in infection of multiple CD4⁺ T cells as these cells make exploratory contacts on the DC surface. While it has long been appreciated that activation of DCs with ligands that induce type I IFN signaling pathway dramatically enhances DC-mediated T cell trans infection, the mechanism by which this occurs has remained unclear until now. Here, we demonstrate that the type I IFN-inducible Siglec-1, CD169, is the DC receptor that captures HIV in a GM3-dependent manner. Selective downregulation of CD169 expression, neutralizing CD169 function, or depletion of GSLs from virions, abrogated DC-mediated HIV-1 capture and trans infection, while exogenous expression of CD169 in receptor-naïve cells rescued GSL-dependent capture and trans infection. HIV-1 particles co-localized with CD169 on DC surface immediately following capture and subsequently within non-lysosomal compartments that redistributed to the DC--T cell infectious synapses upon initiation of T cell contact. Together, these findings describe a novel mechanism of pathogen parasitization of host encoded cellular recognition machinery (GM3--CD169 interaction) for DC-dependent HIV dissemination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1003291

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 68

  1. [1]Cameron PU, Freudenthal PS, Barker JM, Gezelter S, Inaba K, et al (1992) Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257: 383– 387. 1352913
  2. [2]McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, et al (2003) Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300: 1295– 1297. 12730499
  3. [3]Wu L, KewalRamani VN (2006) Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 6: 859– 868. 17063186 PMC1796806
  4. [4]Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, et al (2002) Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 3: 975– 983. 12352970
  5. [5]Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587– 597. 10721995
  6. [6]Garcia E, Pion M, Pelchen-Matthews A, Collinson L, Arrighi JF, et al (2005) HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 6: 488– 501. 15882445
  7. [7]Izquierdo-Useros N, Naranjo-Gomez M, Archer J, Hatch SC, Erkizia I, et al (2009) Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113: 2732– 2741. 18945959 PMC2661860
  8. [9]Engering A, Geijtenbeek TB, van Kooyk Y (2002) Immune escape through C-type lectins on dendritic cells. Trends Immunol 23: 480– 485. 12297419
  9. [13]Gummuluru S, Rogel M, Stamatatos L, Emerman M (2003) Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J Virol 77: 12865– 12874. 14610207 PMC262553
  10. [14]Hatch SC, Archer J, Gummuluru S (2009) Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection. J Virol 83: 3496– 3506. 19193785 PMC2663285
  11. [16]Nguyen DH, Hildreth JE (2000) Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 74: 3264– 3272. 10708443 PMC111827
  12. [17]Ono A, Freed EO (2001) Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A 98: 13925– 13930. 11717449 PMC61143
  13. [20]Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, et al (2006) The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A 103: 2641– 2646. 16481622 PMC1413831
  14. [21]Puryear WB, Yu X, Ramirez NP, Reinhard BM, Gummuluru S (2012) HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells. Proc Natl Acad Sci U S A 109: 7475– 7480. 22529395 PMC3358844
  15. [22]Izquierdo-Useros N, Lorizate M, Contreras FX, Rodriguez-Plata MT, Glass B, et al (2012) Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1. PLoS Biol 10: e1001315. 22545022 PMC3335875
  16. [23]Barton GM, Kagan JC (2009) A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 9: 535– 542. 19556980 PMC3934928
  17. [24]Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7: 255– 266. 17380156
  18. [25]Hartnell A, Steel J, Turley H, Jones M, Jackson DG, et al (2001) Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97: 288– 296. 11133773
  19. [26]Rempel H, Calosing C, Sun B, Pulliam L (2008) Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS One 3: e1967. 18414664 PMC2288672
  20. [27]York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, et al (2007) A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum 56: 1010– 1020. 17328080
  21. [28]Biesen R, Demir C, Barkhudarova F, Grun JR, Steinbrich-Zollner M, et al (2008) Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum 58: 1136– 1145. 18383365
  22. [29]Kirchberger S, Majdic O, Steinberger P, Bluml S, Pfistershammer K, et al (2005) Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol 175: 1145– 1152. 16002716
  23. [30]Baribaud F, Pohlmann S, Leslie G, Mortari F, Doms RW (2002) Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J Virol 76: 9135– 9142. 12186897 PMC136426
  24. [31]Felts RL, Narayan K, Estes JD, Shi D, Trubey CM, et al (2010) 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A 107: 13336– 13341. 20624966 PMC2922156
  25. [32]Delputte PL, Van Gorp H, Favoreel HW, Hoebeke I, Delrue I, et al (2011) Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages. PLoS One 6: e16827. 21359217 PMC3040196
  26. [33]Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109– 1118. 8145033 PMC2191432
  27. [35]Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, et al (2009) Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034– 1038. 19262509 PMC2785041
  28. [36]Sandler NG, Douek DC (2012) Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 10: 655– 666. 22886237
  29. [37]Shi C, Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11: 762– 774. 21984070 PMC3947780
  30. [38]Krutzik SR, Tan B, Li H, Ochoa MT, Liu PT, et al (2005) TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 11: 653– 660. 15880118 PMC1409736
  31. [39]Naik SH, Metcalf D, van Nieuwenhuijze A, Wicks I, Wu L, et al (2006) Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 7: 663– 671. 16680143
  32. [40]Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA (1998) Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480– 483. 9774276
  33. [41]Paquette RL, Hsu NC, Kiertscher SM, Park AN, Tran L, et al (1998) Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol 64: 358– 367. 9738663
  34. [42]Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, et al (2000) Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 191: 1777– 1788. 10811870 PMC2193160
  35. [43]Lin G, Simmons G, Pohlmann S, Baribaud F, Ni H, et al (2003) Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 77: 1337– 1346. 12502850 PMC140807
  36. [44]de Witte L, Bobardt M, Chatterji U, Degeest G, David G, et al (2007) Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc Natl Acad Sci U S A 104: 19464– 19469. 18040049 PMC2148312
  37. [45]Izquierdo-Useros N, Blanco J, Erkizia I, Fernandez-Figueras MT, Borras FE, et al (2007) Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission. J Virol 81: 7559– 7570. 17475656 PMC1933337
  38. [46]Turville SG, Arthos J, MacDonald K, Lynch G, Naif H, et al (2001) HIV gp120 receptors on human dendritic cells. Blood 98: 2482– 2488. 11588046
  39. [47]Wu L, Martin TD, Carrington M, KewalRamani VN (2004) Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 318: 17– 23. 14972530
  40. [48]Vinson M, van der Merwe PA, Kelm S, May A, Jones EY, et al (1996) Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. J Biol Chem 271: 9267– 9272. 8621587
  41. [50]Turville SG, Santos JJ, Frank I, Cameron PU, Wilkinson J, et al (2004) Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103: 2170– 2179. 14630806
  42. [52]Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, et al (2004) DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103: 2648– 2654. 14576049
  43. [53]Moris A, Pajot A, Blanchet F, Guivel-Benhassine F, Salcedo M, et al (2006) Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108: 1643– 1651. 16675708
  44. [55]Gummuluru S, KewalRamani VN, Emerman M (2002) Dendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnover. J Virol 76: 10692– 10701. 12368311 PMC136613
  45. [56]Wu L, Martin TD, Vazeux R, Unutmaz D, KewalRamani VN (2002) Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J Virol 76: 5905– 5914. 12021323 PMC136240
  46. [57]Lee B, Leslie G, Soilleux E, O'Doherty U, Baik S, et al (2001) cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 75: 12028– 12038. 11711593 PMC116098
  47. [58]Nobile C, Petit C, Moris A, Skrabal K, Abastado JP, et al (2005) Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J Virol 79: 5386– 5399. 15827153 PMC1082762
  48. [59]Wang JH, Janas AM, Olson WJ, KewalRamani VN, Wu L (2007) CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1. J Virol 81: 2497– 2507. 17151103 PMC1865928
  49. [60]Hijazi K, Wang Y, Scala C, Jeffs S, Longstaff C, et al (2011) DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4. PLoS One 6: e28307. 22163292 PMC3233575
  50. [61]Cavrois M, Neidleman J, Kreisberg JF, Fenard D, Callebaut C, et al (2006) Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J Virol 80: 1992– 1999. 16439555 PMC1367165
  51. [63]Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, et al (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654– 657. 21613998 PMC3595993
  52. [64]Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, et al (2010) A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467: 214– 217. 20829794 PMC3051279
  53. [65]Wilson SJ, Schoggins JW, Zang T, Kutluay SB, Jouvenet N, et al (2012) Inhibition of HIV-1 particle assembly by 2′,3′-cyclic nucleotide 3′-phosphodiesterase. Cell host & microbe 12: 585– 597. 23084924 PMC3498451
  54. [66]Monteiro VG, Lobato CS, Silva AR, Medina DV, de Oliveira MA, et al (2005) Increased association of Trypanosoma cruzi with sialoadhesin positive mice macrophages. Parasitol Res 97: 380– 385. 16151743
  55. [67]Klaas M, Oetke C, Lewis LE, Erwig LP, Heikema AP, et al (2012) Sialoadhesin Promotes Rapid Proinflammatory and Type I IFN Responses to a Sialylated Pathogen, Campylobacter jejuni. J Immunol 189: 2414– 2422. 22851711 PMC3442253
  56. [68]Vanderheijden N, Delputte PL, Favoreel HW, Vandekerckhove J, Van Damme J, et al (2003) Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages. J Virol 77: 8207– 8215. 12857889 PMC165228
  57. [69]Cavrois M, Neidleman J, Kreisberg JF, Greene WC (2007) In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog 3: e4. 17238285 PMC1779297
  58. [70]Wiley RD, Gummuluru S (2006) Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci U S A 103: 738– 743. 16407131 PMC1334656
  59. [71]Berney C, Herren S, Power CA, Gordon S, Martinez-Pomares L, et al (1999) A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein. J Exp Med 190: 851– 860. 10499923 PMC2195630
  60. [72]Kwan WH, Helt AM, Maranon C, Barbaroux JB, Hosmalin A, et al (2005) Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J Virol 79: 7291– 7299. 15919883 PMC1143643
  61. [73]Zou Z, Chastain A, Moir S, Ford J, Trandem K, et al (2011) Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PLoS One 6: e24559. 21931755 PMC3169630
  62. [74]Zhu P, Liu J, Bess J Jr, Chertova E, Lifson JD, et al (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441: 847– 852. 16728975
  63. [75]O'Reilly MK, Paulson JC (2010) Multivalent ligands for siglecs. Methods Enzymol 478: 343– 363. 20816489 PMC3012384
  64. [76]Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, et al (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83: 3719– 3733. 19176632 PMC2663284
  65. [77]Pitha PM (2011) Innate antiviral response: role in HIV-1 infection. Viruses 3: 1179– 1203. 21994776 PMC3185785
  66. [78]Sagar M, Akiyama H, Etemad B, Ramirez N, Freitas I, et al (2012) Transmembrane Domain Membrane Proximal External Region but Not Surface Unit-Directed Broadly Neutralizing HIV-1 Antibodies Can Restrict Dendritic Cell-Mediated HIV-1 Trans-infection. J Infect Dis 205: 1248– 1257. 22396600 PMC3308909
  67. [79]Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, et al (2003) Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4: 785– 801. 14617360
  68. [80]Dohi T, Nores G, Hakomori S (1988) An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo. Cancer Res 48: 5680– 5685. 3167827

Cited by

Sorted by citations

Authors
Puryear, W. B., Akiyama, H., Geer, S. D., Ramirez, N. P., Yu, X., Reinhard, B. M., & Gummuluru, S.
Affiliations
Boston University (US)
Corresponding author
Gummuluru, Suryaram
Venue
PLoS Pathogens
Published
2013-04-11
Volume
9
Issue
4
Pages
e1003291
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2044086145
Cited by
181
References
12
Citations by year
2026: 14 · 2025: 12 · 2024: 6 · 2023: 10 · 2022: 18 · 2021: 18 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 16 · 2016: 13 · 2015: 14 · 2014: 13 · 2013: 3
FWCI
6.58
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Yale University
  • Institut National de la Santé et de la Recherche Médicale
  • National Institutes of Health (183-H12-5C, gp120, AI064099, CA138509, AI007309)
  • National Cancer Institute (R01CA138509, CA138509)
  • National Institute of Allergy and Infectious Diseases (R01AI064099, AI064099, F32AI084558, T32AI007309)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
HIV-1, dendritic cells, CD169, Siglec-1, type I interferon, trans-infection, viral dissemination, CD4+ T cells, viral capture, myeloid dendritic cells
MeSH terms
Animals, Cell Line, Dendritic Cells, G(M3) Ganglioside, Humans, Signal Transduction, CD4-Positive T-Lymphocytes, HIV-1, Down-Regulation, HIV Infections, Interferon-alpha, RNA Interference, Mice, Rats, HEK293 Cells, Sialic Acid Binding Ig-like Lectin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review